NRX Pharmaceuticals, Inc. Warrant

YTD

ALL

Why Robinhood?

You can watch NRXPW and buy or sell other stocks, ETFs, and their options commission-free!

About NRXPW

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C.

CEO

Jonathan C. Javitt, MD

CEOJonathan C. Javitt, MD

Employees

—

Employees—

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

2017

Founded2017

Employees

—

Employees—

NRXPW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

29.44K

Average volume29.44K

High today

$0.0301

High today$0.0301

Low today

$0.0301

Low today$0.0301

Open price

$0.0301

Open price$0.0301

Volume

513.00

Volume513.00

52 Week high

$0.1751

52 Week high$0.1751

52 Week low

$0.0293

52 Week low$0.0293

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

NRX Pharmaceuticals, Inc. Warrant

Why Robinhood?

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Show more

NRXPW Key Statistics

Popular Stocks

Newly Listed

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C.